$13.48
-0.59-4.19%
Last update: Oct 30, 4:02 PM
Crescent Biopharma Inc (CBIO) Stock Price, Quote, News & History
CBIONASDAQ
Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Residential and Caesars Entertainment.
You can purchase shares of Crescent Biopharma (NASDAQ:CBIO) through any online brokerage.
Other companies in Crescent Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Crescent Biopharma has a consensus price target of $29.00.
The stock price for Crescent Biopharma (NASDAQ: CBIO) is $13.67 last updated October 30, 2026 at 4:02 PM EDT.
There are no upcoming dividends for Crescent Biopharma.
Crescent Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Crescent Biopharma.
Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved...
